ReviewDrug design, development and therapy2020

Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy.

Viswanathan Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.